No Data
JonesTrading Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $44
Wedbush Maintains Alto Neuroscience(ANRO.US) With Hold Rating, Raises Target Price to $24
Jefferies Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $35
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Radnet (RDNT)
A Quick Look at Today's Ratings for Alto Neuroscience(ANRO.US), With a Forecast Between $24 to $28
Alto Neuroscience: Buy Rating Reiterated as Lead Asset Advances and Cash Runway Extends; $28 Price Target Maintained